Abstract: Pyrimidine deriviatives are ubiquination inhibitors that inhibit the ubiquitin ligase activity, particularly of POSH polypeptides, are useful for the treatment of viral infections and neurological disorders.
Abstract: Pyrimidine deriviatives are ubiquination inhibitors that inhibit the ubiquitin ligase activity, particularly of POSH polypeptides, are useful for the treatment of viral infections and neurological disorders.
Type:
Grant
Filed:
November 7, 2007
Date of Patent:
October 9, 2012
Assignee:
Proteologics, Ltd.
Inventors:
Philippe Nakache, Itzchak Angel, Nurit Livnah, Maxim Borovitov
Abstract: Pyridine and pyrimidine derivatives inhibit ubiquitination of human polypeptides, particularly of POSH and POSH-associated proteins such as HERPUD1, and can be used as medicaments for treatment of viral infections caused by virus such as HIV and for treatment of neurological disorders or diseases.
Abstract: Provided are quinazolin-4(3A)-one derivatives, which are inhibitors of the ubiquitin ligase activity of a human polypeptide, particularly to POSH inhibitors, and to compositions and methods for the treatment RING E3 ubiquitin ligase related diseases.
Abstract: Pyrimidine deriviatives are ubiquination inhibitors that inhibit the ubiquitin ligase activity, particularly of POSH polypeptides, are useful for the treatment of viral infections and neurological disorders.
Type:
Application
Filed:
November 7, 2007
Publication date:
July 15, 2010
Applicant:
Proteologics Ltd
Inventors:
Philippe Nakache, Itzchak Angel, Nurit Livnah, Maxim Borovitov
Abstract: The application provides novel complexes of POSH polypeptides and POSH asoociated kinases. The application also provides methods and compositions for treating a POSH-associated diseases such as viral disorders and cancer.
Type:
Application
Filed:
February 5, 2004
Publication date:
November 29, 2007
Applicants:
PROTEOLOGICS, LTD., PROTEOLOGICS. INC.
Abstract: The invention provides, inter alia, methods for identifying substrates for E3 proteins that mediate ligation of ubiquitin or ubiquitin-like proteins.
Abstract: The application discloses novel polypeptides and nucleic acids involved in a variety of biological processes, including viral reproduction. Related methods and compositions are also described.
Type:
Application
Filed:
January 6, 2005
Publication date:
February 16, 2006
Applicant:
Proteologics, Ltd.
Inventors:
Iris Alroy, Tsvika Greener, Shmuel Tuvia, Danny Ben-Avraham
Abstract: The application discloses novel polypeptides and nucleic acids involved in a variety of biological processes, including viral reproduction. Related methods and compositions are also described.
Type:
Application
Filed:
January 7, 2005
Publication date:
January 26, 2006
Applicant:
Proteologics, Ltd.
Inventors:
Iris Alroy, Tsvika Greener, Shmuel Tuvia, Danny Ben-Avraham
Abstract: The application relates to methods of inhibiting a Nef-mediated process in a cell infected with HIV. The application also provides methods and compositions for treating POSH-associated and HERPUD1-associated diseases such as viral disorders.
Abstract: The invention provides, inter alia, methods for identifying substrates for E3 proteins that mediate ligation of ubiquitin or ubiquitin-like proteins.